cladribine has been researched along with Leukemic Infiltration in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bartkowiak, J; Biernat, W; Krykowski, E; Robak, E; Robak, T | 1 |
Juneja, SK; Westerman, DA | 1 |
Chrobák, L; Dĕdic, K; Podzimek, K; Zák, P | 1 |
3 other study(ies) available for cladribine and Leukemic Infiltration
Article | Year |
---|---|
Successful treatment of leukaemia cutis with cladribine in a patient with B-cell chronic lymphocytic leukaemia.
Topics: Aged; Antineoplastic Agents; Cladribine; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemic Infiltration; Male; Skin | 2002 |
Test and teach. Number one hundred and one: Part 1.
Topics: Aged; Antigens, CD; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Diagnosis, Differential; Humans; Immunophenotyping; Immunosuppressive Agents; Leukemia, Hairy Cell; Leukemic Infiltration; Lymphoma; Male; Splenectomy; Splenic Neoplasms; Treatment Outcome | 2000 |
[Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
Topics: Adult; Aged; Antibodies, Monoclonal; Antineoplastic Agents; Bone Marrow Cells; Cladribine; Female; Humans; Immunophenotyping; Leukemia, Hairy Cell; Leukemic Infiltration; Male; Middle Aged; Neoplasm, Residual; Remission Induction | 2000 |